{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T16:46:17Z","timestamp":1777653977579,"version":"3.51.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T00:00:00Z","timestamp":1676505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T00:00:00Z","timestamp":1676505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"New Faculty Startup Fund from Seoul National University in 2020"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Higher blood monocyte counts are related to worse survival in idiopathic pulmonary fibrosis. However, studies evaluating the association between blood monocyte counts and clinical outcomes of idiopathic nonspecific interstitial pneumonia (iNSIP) are lacking. We evaluated the impact of monocyte counts on iNSIP prognosis. iNSIP patients (n\u2009=\u2009126; median age, 60\u00a0years; female, n\u2009=\u200964 [50.8%]) diagnosed by surgical lung biopsy were enrolled and categorized into low (monocyte\u2009&lt;\u2009600\/\u00b5L) and high (monocyte\u2009\u2265\u2009600\/\u00b5L) monocyte groups. The median follow-up duration was 53.0\u00a0months. After adjusting for age, sex, and smoking history, the annual decline in forced vital capacity (FVC) showed differences between the monocyte groups (<jats:italic>P<\/jats:italic><jats:sub>interaction<\/jats:sub>\u2009=\u20090.006) (low vs. high;\u2009\u2212\u200928.49\u00a0mL\/year vs.\u2009\u2212\u200965.76\u00a0mL\/year). The high-monocyte group showed a worse survival rate (<jats:italic>P<\/jats:italic>\u2009=\u20090.01) compared to low monocyte group. The 5-year survival rates were 83% and 72% in the low- and high-monocyte groups, respectively. In the Cox-proportional hazard analysis, older age, male sex, low baseline FVC, and diffusing capacity of the lung for carbon monoxide were independent risk factors for mortality. However, monocyte count (Hazard ratio 1.61, <jats:italic>P<\/jats:italic>\u2009=\u20090.126) was not an independent prognostic factor. Although high monocyte count might be associated with faster lung function decline, it could not independently predict survival in iNSIP.<\/jats:p>","DOI":"10.1038\/s41598-023-28638-5","type":"journal-article","created":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T16:02:48Z","timestamp":1676563368000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Correlation of monocyte counts with clinical outcomes in idiopathic nonspecific interstitial pneumonia"],"prefix":"10.1038","volume":"13","author":[{"given":"Tae Hun","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyung-Jun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myung Jin","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byoung Soo","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeon Wook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Yoon","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeon Joo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young-Jae","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae Ho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Haeng","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong Sun","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,16]]},"reference":[{"issue":"4","key":"28638_CR1","doi-asserted-by":"publisher","first-page":"269","DOI":"10.4046\/trd.2018.0090","volume":"82","author":"SW Park","year":"2019","unstructured":"Park, S. W. et al. Korean guidelines for diagnosis and management of interstitial lung diseases: Part 1. Introduction. Tuberc. Respir. Dis. (Seoul) 82(4), 269\u2013276 (2019).","journal-title":"Tuberc. Respir. Dis. (Seoul)"},{"issue":"6","key":"28638_CR2","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","volume":"188","author":"WD Travis","year":"2013","unstructured":"Travis, W. D. et al. An official American Thoracic Society\/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am. J. Respir. Crit. Care Med. 188(6), 733\u2013748 (2013).","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"6","key":"28638_CR3","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","volume":"183","author":"G Raghu","year":"2011","unstructured":"Raghu, G. et al. An official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: Evidence-based guidelines for diagnosis and management. Am. J. Respir. Crit. Care Med. 183(6), 788\u2013824 (2011).","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"153","key":"28638_CR4","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0109-2019","volume":"28","author":"V Cottin","year":"2019","unstructured":"Cottin, V. Treatment of progressive fibrosing interstitial lung diseases: A milestone in the management of interstitial lung diseases. Eur. Respir. Rev. 28(153), 190109 (2019).","journal-title":"Eur. Respir. Rev."},{"issue":"12","key":"28638_CR5","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1164\/rccm.200611-1685OC","volume":"177","author":"WD Travis","year":"2008","unstructured":"Travis, W. D. et al. Idiopathic nonspecific interstitial pneumonia: Report of an American Thoracic Society project. Am. J. Respir. Crit. Care Med. 177(12), 1338\u20131347 (2008).","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"28638_CR6","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1183\/09031936.00158507","volume":"33","author":"IN Park","year":"2009","unstructured":"Park, I. N. et al. Clinical course and lung function change of idiopathic nonspecific interstitial pneumonia. Eur. Respir. J. 33(1), 68\u201376 (2009).","journal-title":"Eur. Respir. J."},{"issue":"1","key":"28638_CR7","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s12931-017-0686-7","volume":"18","author":"SH Lee","year":"2017","unstructured":"Lee, S. H. et al. Factors affecting treatment outcome in patients with idiopathic nonspecific interstitial pneumonia: A nationwide cohort study. Respir. Res. 18(1), 204 (2017).","journal-title":"Respir. Res."},{"issue":"6","key":"28638_CR8","doi-asserted-by":"publisher","first-page":"661","DOI":"10.3346\/jkms.2012.27.6.661","volume":"27","author":"JY Lee","year":"2012","unstructured":"Lee, J. Y. et al. Treatment response and long term follow-up results of nonspecific interstitial pneumonia. J. Korean Med. Sci. 27(6), 661\u2013667 (2012).","journal-title":"J. Korean Med. Sci."},{"issue":"3","key":"28638_CR9","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1183\/09031936.00148613","volume":"45","author":"H Nunes","year":"2015","unstructured":"Nunes, H. et al. Nonspecific interstitial pneumonia: Survival is influenced by the underlying cause. Eur. Respir. J. 45(3), 746\u2013755 (2015).","journal-title":"Eur. Respir. J."},{"issue":"7","key":"28638_CR10","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1164\/rccm.202108-1967OC","volume":"205","author":"JS Kim","year":"2022","unstructured":"Kim, J. S. et al. Associations of monocyte count and other immune cell types with interstitial lung abnormalities. Am. J. Respir. Crit. Care Med. 205(7), 795\u2013805 (2022).","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5","key":"28638_CR11","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1164\/rccm.201010-1719OC","volume":"184","author":"MA Gibbons","year":"2011","unstructured":"Gibbons, M. A. et al. Ly6Chi monocytes direct alternatively activated profibrotic macrophage regulation of lung fibrosis. Am. J. Respir. Crit. Care Med. 184(5), 569\u2013581 (2011).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"28638_CR12","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1111\/his.12950","volume":"69","author":"A Churg","year":"2016","unstructured":"Churg, A. & Bilawich, A. Confluent fibrosis and fibroblast foci in fibrotic non-specific interstitial pneumonia. Histopathology 69, 128\u2013135. https:\/\/doi.org\/10.1111\/his.12950 (2016).","journal-title":"Histopathology"},{"issue":"3","key":"28638_CR13","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.immuni.2016.02.015","volume":"44","author":"TA Wynn","year":"2016","unstructured":"Wynn, T. A. & Vannella, K. M. Macrophages in tissue repair, regeneration, and fibrosis. Immunity 44(3), 450\u2013462 (2016).","journal-title":"Immunity"},{"issue":"6","key":"28638_CR14","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S2213-2600(18)30508-3","volume":"7","author":"MKD Scott","year":"2019","unstructured":"Scott, M. K. D. et al. Increased monocyte count as a cellular biomarker for poor outcomes in fibrotic diseases: A retrospective, multicentre cohort study. Lancet Respir. Med. 7(6), 497\u2013508 (2019).","journal-title":"Lancet Respir. Med."},{"key":"28638_CR15","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","volume":"205","author":"G Raghu","year":"2022","unstructured":"Raghu, G. et al. Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: An Official ATS\/ERS\/JRS\/ALAT Clinical Practice Guideline. Am. J. Respir. Crit. Care Med. 205, e18\u2013e47. https:\/\/doi.org\/10.1164\/rccm.202202-0399ST (2022).","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"18","key":"28638_CR16","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1056\/NEJMoa1908681","volume":"381","author":"KR Flaherty","year":"2019","unstructured":"Flaherty, K. R. et al. Nintedanib in progressive fibrosing interstitial lung diseases. N. Engl. J. Med. 381(18), 1718\u20131727 (2019).","journal-title":"N. Engl. J. Med."},{"key":"28638_CR17","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1186\/s12931-021-01879-6","volume":"22","author":"BS Kwon","year":"2021","unstructured":"Kwon, B. S. et al. Progressive fibrosing interstitial lung disease: Prevalence and clinical outcome. Respir. Res. 22, 282. https:\/\/doi.org\/10.1186\/s12931-021-01879-6 (2021).","journal-title":"Respir. Res."},{"key":"28638_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.790204","author":"SE Torrisi","year":"2021","unstructured":"Torrisi, S. E. et al. Outcomes and incidence of PF-ILD according to different definitions in a real-world setting. Front. Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2021.790204 (2021).","journal-title":"Front. Pharmacol."},{"key":"28638_CR19","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s12931-018-0857-1","volume":"19","author":"MJ Cecchini","year":"2018","unstructured":"Cecchini, M. J., Hosein, K., Howlett, C. J., Joseph, M. & Mura, M. Comprehensive gene expression profiling identifies distinct and overlapping transcriptional profiles in non-specific interstitial pneumonia and idiopathic pulmonary fibrosis. Respir. Res. 19, 153. https:\/\/doi.org\/10.1186\/s12931-018-0857-1 (2018).","journal-title":"Respir. Res."},{"issue":"7","key":"28638_CR20","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1164\/rccm.200607-912OC","volume":"175","author":"JH Park","year":"2007","unstructured":"Park, J. H. et al. Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes. Am. J. Respir. Crit. Care Med. 175(7), 705\u2013711 (2007).","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"28638_CR21","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1378\/chest.07-0323","volume":"132","author":"IN Park","year":"2007","unstructured":"Park, I. N. et al. Acute exacerbation of interstitial pneumonia other than idiopathic pulmonary fibrosis. Chest 132(1), 214\u2013220 (2007).","journal-title":"Chest"},{"issue":"6","key":"28638_CR22","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1183\/09031936.02.00244002","volume":"19","author":"RL Riha","year":"2002","unstructured":"Riha, R. L. et al. Survival of patients with biopsy-proven usual interstitial pneumonia and nonspecific interstitial pneumonia. Eur. Respir. J. 19(6), 1114\u20131118 (2002).","journal-title":"Eur. Respir. J."},{"key":"28638_CR23","doi-asserted-by":"publisher","first-page":"175346662210894","DOI":"10.1177\/17534666221089468","volume":"16","author":"HK Cho","year":"2022","unstructured":"Cho, H. K. et al. Clinical characteristics and prognostic factors of fibrotic nonspecific interstitial pneumonia. Ther. Adv. Respir. Dis. 16, 17534666221089468 (2022).","journal-title":"Ther. Adv. Respir. Dis."},{"issue":"1","key":"28638_CR24","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1164\/rccm.202003-0669OC","volume":"204","author":"M Kreuter","year":"2021","unstructured":"Kreuter, M. et al. Monocyte count as a prognostic biomarker in patients with idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 204(1), 74\u201381 (2021).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"28638_CR25","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1164\/rccm.201604-0801CI","volume":"194","author":"HR Collard","year":"2016","unstructured":"Collard, H. R. et al. Acute exacerbation of idiopathic pulmonary fibrosis. An International Working Group Report. Am. J. Respir. Crit. Care Med. 194, 265\u2013275. https:\/\/doi.org\/10.1164\/rccm.201604-0801CI (2016).","journal-title":"Am. J. Respir. Crit. Care Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-28638-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-28638-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-28638-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T16:04:50Z","timestamp":1676563490000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-28638-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,16]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["28638"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-28638-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,16]]},"assertion":[{"value":"16 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2804"}}